EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access · CC BY-NC-ND 4.0

Facial deformation following treatment for pediatric head and neck rhabdomyosarcoma; the difference between treatment modalities. Results of a trans‐Atlantic, multicenter cross‐sectional cohort study

Marinka L F Hol iD, Daniel J Indelicato iD, Olga Slater, Frederic Kolb, Richard J Hewitt, Juling Ong, Alfred G Becking, Jenny Gains, Julie Bradley, Eric Sandler, Mark N Gaze iD, Bradley Pieters und 7 weitere

Pediatric Blood & Cancer · 2023

DOI: 10.1002/pbc.30412 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Pediatric Blood & Cancer, 2023. Verfasst von Marinka L F Hol und 18 weiteren Autor:innen. Beteiligte Einrichtung: Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Rhabdomyosarcoma, Embryonal, Rhabdomyosarcoma. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Cancer Research UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The four different local therapy strategies used for head and neck rhabdomyosarcoma (HNRMS) include proton therapy (PT), photon therapy (RT), surgery with radiotherapy (Paris‐method), and surgery with brachytherapy (AMORE). Local control and survival is comparable; however, the impact of these different treatments on facial deformation is still poorly understood. This study aims to quantify facial deformation and investigates the differences in facial deformation between treatment modalities.

Methods

Across four European and North American institutions, HNRMS survivors treated between 1990 and 2017, more than 2 years post treatment, had a 3D photograph taken. Using dense surface modeling, we computed facial signatures for each survivor to show facial deformation relative to 35 age–sex–ethnicity‐matched controls. Additionally, we computed individual facial asymmetry.

Findings

A total of 173 HNRMS survivors were included, survivors showed significantly reduced facial growth ( p < .001) compared to healthy controls. Partitioned by tumor site, there was reduced facial growth in survivors with nonparameningeal primaries ( p = .002), and parameningeal primaries ( p ≤.001), but not for orbital primaries ( p = .080) All patients were significantly more asymmetric than healthy controls, independent of treatment modality ( p ≤ .001). There was significantly more facial deformation in orbital patients when comparing RT to AMORE ( p = .046). In survivors with a parameningeal tumor, there was significantly less facial deformation in PT when compared to RT ( p = .009) and Paris‐method ( p = .007).

Interpretation

When selecting optimal treatment, musculoskeletal facial outcomes are an expected difference between treatment options. These anticipated differences are currently based on clinicians’ bias, expertise, and experience. These data supplement clinician judgment with an objective analysis highlighting the impact of patient age and tumor site between existing treatment options.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Head and Neck NeoplasmsRhabdomyosarcoma, EmbryonalRhabdomyosarcomaChildHumansInfantCross-Sectional StudiesCohort StudiesCombined Modality Therapy

Stichwörter der Autor:innen

facial asymmetryfacial deformationlate effectsprotontherapyrhabdomyosarcomasurgery

Autor:innen und Institutionen

  • Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Department of Otorhinolaryngology, University of Utrecht, Utrecht, The Netherlands.
  • Department of Maxillofacial Surgery, Amsterdam UMC, Duivendrecht, The Netherlands.
  • Department of Radiation Oncology, University of Florida Proton Therapy Institute, Jacksonville, Florida, USA.
  • Department of Pediatric Oncology, Great Ormond Street Hospital, NHS Foundation Trust, London, UK.
  • Department of Plastic Surgery, Institute Gustave Roussy, Paris, France.

ORCID-Profile: Marinka L F Hol, Daniel J Indelicato, Mark N Gaze, Raquel Dávila Fajardo

Förderung

  • Cancer Research UK

Zitieren

APA

Hol, M. L. F., Indelicato, D. J., Slater, O., Kolb, F., Hewitt, R. J., Ong, J., Becking, A. G., Gains, J., Bradley, J., Sandler, E., Gaze, M. N., Pieters, B., Mandeville, H., Fajardo, R. D., Schoot, R., Merks, J. H. M., Hammond, P., Smeele, L. E., & Suttie, M. (2023). Facial deformation following treatment for pediatric head and neck rhabdomyosarcoma; the difference between treatment modalities. Results of a trans‐Atlantic, multicenter cross‐sectional cohort study. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.30412

Vancouver

Hol MLF, Indelicato DJ, Slater O, Kolb F, Hewitt RJ, Ong J, et al. Facial deformation following treatment for pediatric head and neck rhabdomyosarcoma; the difference between treatment modalities. Results of a trans‐Atlantic, multicenter cross‐sectional cohort study. Pediatric Blood & Cancer. 2023. doi:10.1002/pbc.30412

BibTeX
@article{Hol2023,
  author = {Hol, Marinka L F and Indelicato, Daniel J and Slater, Olga and Kolb, Frederic and Hewitt, Richard J and Ong, Juling and Becking, Alfred G and Gains, Jenny and Bradley, Julie and Sandler, Eric and Gaze, Mark N and Pieters, Bradley and Mandeville, Henry and Fajardo, Raquel Dávila and Schoot, Reineke and Merks, Johannes H M and Hammond, Peter and Smeele, Ludwig E and Suttie, Michael},
  title = {Facial deformation following treatment for pediatric head and neck rhabdomyosarcoma; the difference between treatment modalities. Results of a trans‐Atlantic, multicenter cross‐sectional cohort study},
  journal = {Pediatric Blood & Cancer},
  year = {2023},
  doi = {10.1002/pbc.30412}
}
Kostenlos starten →